Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials.
about
Current clinical immunotherapeutic approaches for head and neck cancerCIViC databasePrognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapySurgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer.Alcohol and Tobacco Increases Risk of High Risk HPV Infection in Head and Neck Cancer Patients: Study from North-East Region of India.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesHuman papillomavirus genotype and oropharynx cancer survival in the United States of America.Understanding the impact of survival and human papillomavirus tumor status on timing of recurrence in oropharyngeal squamous cell carcinoma.National treatment patterns in patients presenting with Stage IVC head and neck cancer: analysis of the National Cancer Database.Human Papillomavirus-Associated Oropharyngeal Cancer: Defining Risk Groups and Clinical Trials.The epidemiology of the human papillomavirus related to oropharyngeal head and neck cancer.Prognostic significance of non-HPV16 genotypes in oropharyngeal squamous cell carcinoma.Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.Treatment de-intensification strategies for head and neck cancer.Emerging insights into recurrent and metastatic human papillomavirus-related oropharyngeal squamous cell carcinoma.The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma.The prognostic impact of human papillomavirus status following treatment failure in oropharyngeal cancer.The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.Human Papilloma Virus in Oral Cavity Cancer and Relation to Change in Quality of Life Following Treatment-a Pilot Study from Northern India.Characterization of functionally active gene fusions in human papillomavirus related oropharyngeal squamous cell carcinoma.Disease-free survival after salvage therapy for recurrent oropharyngeal squamous cell carcinoma.Emerging insights into recurrent and metastatic human papillomavirus‐related oropharyngeal squamous cell carcinoma.NSD1- and NSD2-damaging mutations define a subset of laryngeal tumors with favorable prognosis.Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.Improved outcomes in PI3K-pathway-altered metastatic HPV oropharyngeal cancer
P2860
Q26745411-895C9D2C-643B-4EEE-99C1-034CA888EDFAQ27612411-23F9700D-7519-4F47-B7D7-8E75D3F1A123Q33884484-18D4E9B7-513C-4470-BC95-E0F5AEA3C209Q35688621-D6332F38-6001-48E4-9E31-56DA05E4E1BAQ35810101-445DA693-1241-4323-A270-036BCD271895Q35838231-3F932253-C2D9-43E8-AF1D-73B8BE63CE82Q36338604-A4C135AF-94D2-477E-8E02-6FCDB32AB52AQ36405555-01C79493-CE8B-4B61-9590-3AF09407D51FQ37441503-CC6C632C-312A-44A5-B640-49A01F175279Q38583292-CF95AF3D-1634-4CDE-816A-D896B7CF6FDBQ38723059-72899B4B-AE65-4582-B36D-67AE10ADD7DCQ38816144-DBBDC57B-6E36-41DF-9B72-D16E370298F4Q38971554-185D801E-B097-4D63-8E78-32FFD19672D5Q38971558-A91C8917-F727-45E8-B9ED-BF16B9D97FDEQ38984523-9F8031A2-92F2-4741-8AF1-2367C246C122Q40046181-022EBC15-A010-4566-A732-D16089AFF7AAQ40081693-EA30D50D-4591-4888-A0F2-44C1EB609C0BQ40113260-D3FF5057-6559-4893-BC66-6B2FAED57A48Q40129971-91899857-457B-41B0-8ACB-28C42890731BQ40441462-466AA814-9BF2-49BE-A025-F83D22FB8C91Q40765189-CBFF4285-04C5-4EA7-B449-95EC06A1CF7DQ41132101-A6F2C65D-92D7-4322-A17B-BBA24E088ADAQ46699165-1128B3F7-CD76-407A-BA06-22943013CA4AQ47122819-5E46F027-F7B0-4D01-A8FD-0171C775C556Q52836574-A65257E4-927E-47A6-B204-0AC718B77E38Q58760723-40B582D5-EDC0-43B1-B84A-313CE5505A36
P2860
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Prognostic significance of hum ...... erative Oncology Group trials.
@ast
Prognostic significance of hum ...... erative Oncology Group trials.
@en
Prognostic significance of hum ...... erative Oncology Group trials.
@nl
type
label
Prognostic significance of hum ...... erative Oncology Group trials.
@ast
Prognostic significance of hum ...... erative Oncology Group trials.
@en
Prognostic significance of hum ...... erative Oncology Group trials.
@nl
altLabel
Prognostic significance of hum ...... perative Oncology Group trials
@en
prefLabel
Prognostic significance of hum ...... erative Oncology Group trials.
@ast
Prognostic significance of hum ...... erative Oncology Group trials.
@en
Prognostic significance of hum ...... erative Oncology Group trials.
@nl
P2093
P2860
P3181
P356
P1433
P1476
Prognostic significance of hum ...... erative Oncology Group trials.
@en
P2093
A A Forastiere
A M Egloff
B Burtness
M Ghebremichael
P2860
P304
P3181
P356
10.1093/ANNONC/MDU167
P577
2014-07-01T00:00:00Z